Post by dave on Mar 13, 2016 23:30:00 GMT
I was trying to glean some more information by taking a look at the athersys website. Unfortunately, it's a real mess and doesn't do much to attract potential investors. First off, there is a lot of information presented in a redundant and confusing way. They have tabs for their multistem program as well as their clinical programs, which again (no pun intended) is redundant. Their graphic with the overview of the clinical programs is very low resolution and hard to read. I'm learning a lot more just by going through information on this board, conference calls, and sec filings.
I was trying to find some information on their GVHD trial. The only real quantitative data I encountered was that patients receiving multi-stem in phase I, on the whole did 30% better than those that didn't. If anyone can point me to some more hard data on what they found on this trial I would appreciate it. I don't see any results data posted for any of their trials on us fda clinical trial site.
There is information on their website about a small molecule program related to treatment of obesity and schizophrenia. Seems these efforts have been suspended? Would be great if they updated the website to reflect current operations, otherwise seems like a very exciting company.
I was trying to find some information on their GVHD trial. The only real quantitative data I encountered was that patients receiving multi-stem in phase I, on the whole did 30% better than those that didn't. If anyone can point me to some more hard data on what they found on this trial I would appreciate it. I don't see any results data posted for any of their trials on us fda clinical trial site.
There is information on their website about a small molecule program related to treatment of obesity and schizophrenia. Seems these efforts have been suspended? Would be great if they updated the website to reflect current operations, otherwise seems like a very exciting company.
